Clinical Trials Act 2011Section 33
33. Disclosure of interest
(1) Where any member of the Council, Pharmacovigilance
Committee or Ethics Committee, or any person related to him by blood or
marriage, has a financial or other material interest in relation to any matter
before the Council, Pharmacovigilance Committee or Ethics Committee,
as the case may be, that member –
(a) shall disclose the nature of the interest at or before the
meeting convened to discuss the matter; and
(b) shall not take part in any deliberations of the Council,
Pharmacovigilance Committee or Ethics Committee, as
the case may be, relating to the matter.
(2) Where any member of the Council, Pharmacovigilance
Committee or Ethics Committee has or acquires any financial interest in
any clinical trial in Mauritius or elsewhere, he shall inform the Council,
Pharmacovigilance Committee or Ethics Committee, as the case may be, in
writing of such interest.